New Delhi, Chemicals and Fertilisers Minister D V Sadananda Gowda has said that a total of 34 lakh 50 thousand vials of Remdesivir has been allocated to States and Union …
34.50 lakh vials of Remdesivir allocated to States,Minister Sadananda Gowda Read More
New Delhi, The Prime Minister chaired a meeting to review steps taken to boost oxygen availability in the country. The PM emphasized that there was an immediate need to augment …
PM chairs a high-level meeting on measures to increase supply of oxygen Read More
New Delhi, Minister of State for Chemicals & Fertilizers Mansukh Mandaviya informed that 25 new manufacturing sites for Remdesivir’s production have been approved since 12th April. He said, “Production capacity …
5 new manufacturing sites approved for Remdesivir production Read More
New Delhi, Various steps have been taken by Government of India to address the emerging issues for effective management of the recent unprecendented spike in COVID19 cases across various States …
Union Government allocates supply of Remdesivir to 19 States Read More
Geneva : Anti-viral drug remdesivir has little or no effect in the recovery and mortality of hospitalised Covid-19 patients, said a World Health Organisation (WHO) study, giving a big blow …
Remdesivir does not help hospitalised Covid-19 patients: WHO study Read More
Brussels: The European Commission has signed a joint procurement framework contract with the pharmaceutical company Gilead for the supply of up to 500,000 treatment courses of Remdesivir against the Covid-19 …
European Commission signs joint procurement contract for Remdesivir Read More
New Delhi, Jubilant Life Sciences Ltd on Monday announced that its subsidiary, Jubilant Generics, has launched remdesivir for injection, under the brand name ‘JUBI-R’, in the Indian market at a …
Jubilant Life Sciences launches remdesivir for injection Read More
Beijing: US-based Gilead Sciences’ remdesivir, a potential antiviral drug to treat COVID-19 patients and is under several trials around the world, has reportedly failed to produce desired results during a Chinese …
Chinese study says Gilead’s remdesivir failed, firm says report ‘inconclusive’ Read More